Review



caption a7 compound control antibiotic e faecium atcc 700221 e  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC caption a7 compound control antibiotic e faecium atcc 700221 e
    MICs in μg/mL (μM) of HSGN-218 and control antibiotics against vancomycin-resistant enterococci (VRE) and Escherichia coli isolates.
    Caption A7 Compound Control Antibiotic E Faecium Atcc 700221 E, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 551 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caption+a7+antibiotic/Enterococcus+faecium+(Orla-Jensen)+Schleifer+and+Kilpper-Balz/pmc09064041-110-31-37
    Average 96 stars, based on 551 article reviews
    caption a7 compound control antibiotic e faecium atcc 700221 e - by Bioz Stars, 2026-11
    96/100 stars

    Images

    1) Product Images from "Ultrapotent Inhibitor of Clostridioides difficile Growth, which Suppresses Recurrence in vivo"

    Article Title: Ultrapotent Inhibitor of Clostridioides difficile Growth, which Suppresses Recurrence in vivo

    Journal: Journal of medicinal chemistry

    doi: 10.1021/acs.jmedchem.0c01198


    Figure Legend Snippet: MICs in μg/mL (μM) of HSGN-218 and control antibiotics against vancomycin-resistant enterococci (VRE) and Escherichia coli isolates.

    Techniques Used: Control, Mutagenesis

    Related Articles

    Derivative Assay:

    Article Title: A Tick Antivirulence Protein Potentiates Antibiotics against Staphylococcus aureus
    Article Snippet: .. Overall, these results demonstrate synergism of three antibiotics, gentamicin, ciprofloxacin, and daptomycin, belonging to varied classes, when combined with IAFGP or P1. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic tested MIC (μg/ml) MIC (μg/ml) + 0.1 mg/ml IAFGP c MIC (μg/ml) + 0.1 mg/ml P1 c SA113 a USA300 b SA113 USA300 SA113 USA300 Gentamicin 0.63–1.25 1.25–2.5 0.16–0.31 0.31–0.63 0.08–0.16 0.31–0.63 Ciprofloxacin 1.25–2.5 R 0.31–0.63 R 0.16–0.31 R Daptomycin 1.25–2.5 2.5–5 0.08–0.16 0.08–0.16 0.08–0.16 0.08–0.16 Open in a separate window a SA113 S. aureus strain (ATCC 35556) is derived from laboratory strain NCTC 8325. b MRSA isolate USA300 JE2 is a plasmid-cured derivative of strain LAC. .. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic tested MIC (μg/ml) MIC (μg/ml) + 0.1 mg/ml IAFGP c MIC (μg/ml) + 0.1 mg/ml P1 c SA113 a USA300 b SA113 USA300 SA113 USA300 Gentamicin 0.63–1.25 1.25–2.5 0.16–0.31 0.31–0.63 0.08–0.16 0.31–0.63 Ciprofloxacin 1.25–2.5 R 0.31–0.63 R 0.16–0.31 R Daptomycin 1.25–2.5 2.5–5 0.08–0.16 0.08–0.16 0.08–0.16 0.08–0.16 Open in a separate window a SA113 S. aureus strain (ATCC 35556) is derived from laboratory strain NCTC 8325. b MRSA isolate USA300 JE2 is a plasmid-cured derivative of strain LAC.

    Plasmid Preparation:

    Article Title: A Tick Antivirulence Protein Potentiates Antibiotics against Staphylococcus aureus
    Article Snippet: .. Overall, these results demonstrate synergism of three antibiotics, gentamicin, ciprofloxacin, and daptomycin, belonging to varied classes, when combined with IAFGP or P1. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic tested MIC (μg/ml) MIC (μg/ml) + 0.1 mg/ml IAFGP c MIC (μg/ml) + 0.1 mg/ml P1 c SA113 a USA300 b SA113 USA300 SA113 USA300 Gentamicin 0.63–1.25 1.25–2.5 0.16–0.31 0.31–0.63 0.08–0.16 0.31–0.63 Ciprofloxacin 1.25–2.5 R 0.31–0.63 R 0.16–0.31 R Daptomycin 1.25–2.5 2.5–5 0.08–0.16 0.08–0.16 0.08–0.16 0.08–0.16 Open in a separate window a SA113 S. aureus strain (ATCC 35556) is derived from laboratory strain NCTC 8325. b MRSA isolate USA300 JE2 is a plasmid-cured derivative of strain LAC. .. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic tested MIC (μg/ml) MIC (μg/ml) + 0.1 mg/ml IAFGP c MIC (μg/ml) + 0.1 mg/ml P1 c SA113 a USA300 b SA113 USA300 SA113 USA300 Gentamicin 0.63–1.25 1.25–2.5 0.16–0.31 0.31–0.63 0.08–0.16 0.31–0.63 Ciprofloxacin 1.25–2.5 R 0.31–0.63 R 0.16–0.31 R Daptomycin 1.25–2.5 2.5–5 0.08–0.16 0.08–0.16 0.08–0.16 0.08–0.16 Open in a separate window a SA113 S. aureus strain (ATCC 35556) is derived from laboratory strain NCTC 8325. b MRSA isolate USA300 JE2 is a plasmid-cured derivative of strain LAC.

    Mann-Whitney U-Test:

    Article Title: Comparative Activity of Ceftriaxone, Ciprofloxacin, and Gentamicin as a Function of Bacterial Growth Rate Probed by Escherichia coli Chromosome Replication in the Mouse Peritonitis Model
    Article Snippet: .. *, P < 0.05; **, P < 0.01; ns, P > 0.05 by Mann-Whitney U test. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic a Phenotype b MIC (mg/liter) Interpretive category (EUCAST/CLSI) c CRO WT 0.125 S/S MUT 0.125 S/S CIP WT 0.016 S/S MUT 0.016 S/S GEN WT 0.125 S/S MUT 1 S/S Open in a separate window a CRO, ceftriaxone; CIP, ciprofloxacin; GEN, gentamicin. b WT, wild type (ATCC 25922); MUT, mutant (ALO 4783). c S, susceptible. ..

    Mutagenesis:

    Article Title: Comparative Activity of Ceftriaxone, Ciprofloxacin, and Gentamicin as a Function of Bacterial Growth Rate Probed by Escherichia coli Chromosome Replication in the Mouse Peritonitis Model
    Article Snippet: .. *, P < 0.05; **, P < 0.01; ns, P > 0.05 by Mann-Whitney U test. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic a Phenotype b MIC (mg/liter) Interpretive category (EUCAST/CLSI) c CRO WT 0.125 S/S MUT 0.125 S/S CIP WT 0.016 S/S MUT 0.016 S/S GEN WT 0.125 S/S MUT 1 S/S Open in a separate window a CRO, ceftriaxone; CIP, ciprofloxacin; GEN, gentamicin. b WT, wild type (ATCC 25922); MUT, mutant (ALO 4783). c S, susceptible. ..

    In Vitro:

    Article Title: Impact of Therapeutic Treatment with β-Lactam on Transfer of the bla CTX-M-9 Resistance Gene from Salmonella enterica Serovar Virchow to Escherichia coli in Gnotobiotic Rats
    Article Snippet: .. Transconjugants were considered to be ESBL-positive strains at the epidemiological EUCAST cutoff value. table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Antibiotic Note a Susceptibility (S) or resistance (R) (MIC [μg/ml]) E. coli ATCC 25922 Donor S. enterica serovar Virchow 3464b Recipient E. coli J5 E. coli J5(p3464b) transconjugant in vitro b E. coli J5(p3464b) transconjugant b Before treatment 7 days posttreatment 12 days posttreatment Amoxicillin-clavulanic acid A, D S (4) R (8) S (4) R (8) R (32) R (32) R (32) Ampicillin A, D, E S (4) R (128) S (4) R (128) R (64) R (32) R (32) Cefixime B, D, E S (0.13) R (8) S (0.13) R (8) R (8) R (8) R (8) Cefotaxime A, C, E S (0.03) R (>8) S (0.03) R (8) R (0.50) R (0.50) R (1) Cefoxitin A, C S (4) S (16) S (4) S (4) R (32) S (16) S (16) Ceftazidime A, C, E S (0.13) R (8) S (0.13) R (2) R (4) R (2) R (2) Ceftiofur A, C, E S (0.25) R (>8) S (0.25) R (8) R (1) R (1) R (1) Cefuroxime A, C, E S (2) R (>32) S (2) R (32) R (32) R (32) R (32) Nalidixic acid A, D S (4) R (256) S (4) S (4) S (4) S (8) S (8) Streptomycin A, C S (2) R (128) S (2) R (16) S (2) S (2) S (2) Sulfamethoxazole A, D S (8) R (>512) S (8) R (>512) S (8) S (32) S (32) Tetracycline A, D S (1) R (64) S (1) R (16) S (1) S (2) S (2) Trimethoprim A, D S (0.50) R (>64) S (0.50) R (16) S (0.50) S (1) S (1) Trimethoprim-sulfamethoxazole A, D S (<1) R (>16) S (<1) R (16) S (1) S (1) S (1) Open in a separate window a A, the MICs of antimicrobial agents were determined by the broth microdilution method; B, the MICs of cefixime were determined with Etest strips; C, results were interpretative of susceptible or resistant strains according to the criteria proposed by EUCAST; D, results were interpretative of susceptible or resistant strains according to the criteria proposed by CLSI; E, resistance to this antibiotic was presumably mediated by CTX-M-9 enzyme. b The MICs of one of the four isolated transconjugants are presented in the table (all transconjugants have the same susceptibility values). ..

    Isolation:

    Article Title: Impact of Therapeutic Treatment with β-Lactam on Transfer of the bla CTX-M-9 Resistance Gene from Salmonella enterica Serovar Virchow to Escherichia coli in Gnotobiotic Rats
    Article Snippet: .. Transconjugants were considered to be ESBL-positive strains at the epidemiological EUCAST cutoff value. table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Antibiotic Note a Susceptibility (S) or resistance (R) (MIC [μg/ml]) E. coli ATCC 25922 Donor S. enterica serovar Virchow 3464b Recipient E. coli J5 E. coli J5(p3464b) transconjugant in vitro b E. coli J5(p3464b) transconjugant b Before treatment 7 days posttreatment 12 days posttreatment Amoxicillin-clavulanic acid A, D S (4) R (8) S (4) R (8) R (32) R (32) R (32) Ampicillin A, D, E S (4) R (128) S (4) R (128) R (64) R (32) R (32) Cefixime B, D, E S (0.13) R (8) S (0.13) R (8) R (8) R (8) R (8) Cefotaxime A, C, E S (0.03) R (>8) S (0.03) R (8) R (0.50) R (0.50) R (1) Cefoxitin A, C S (4) S (16) S (4) S (4) R (32) S (16) S (16) Ceftazidime A, C, E S (0.13) R (8) S (0.13) R (2) R (4) R (2) R (2) Ceftiofur A, C, E S (0.25) R (>8) S (0.25) R (8) R (1) R (1) R (1) Cefuroxime A, C, E S (2) R (>32) S (2) R (32) R (32) R (32) R (32) Nalidixic acid A, D S (4) R (256) S (4) S (4) S (4) S (8) S (8) Streptomycin A, C S (2) R (128) S (2) R (16) S (2) S (2) S (2) Sulfamethoxazole A, D S (8) R (>512) S (8) R (>512) S (8) S (32) S (32) Tetracycline A, D S (1) R (64) S (1) R (16) S (1) S (2) S (2) Trimethoprim A, D S (0.50) R (>64) S (0.50) R (16) S (0.50) S (1) S (1) Trimethoprim-sulfamethoxazole A, D S (<1) R (>16) S (<1) R (16) S (1) S (1) S (1) Open in a separate window a A, the MICs of antimicrobial agents were determined by the broth microdilution method; B, the MICs of cefixime were determined with Etest strips; C, results were interpretative of susceptible or resistant strains according to the criteria proposed by EUCAST; D, results were interpretative of susceptible or resistant strains according to the criteria proposed by CLSI; E, resistance to this antibiotic was presumably mediated by CTX-M-9 enzyme. b The MICs of one of the four isolated transconjugants are presented in the table (all transconjugants have the same susceptibility values). ..



    Similar Products

    96
    ATCC caption a7 compound control antibiotic e faecium atcc 700221 e
    MICs in μg/mL (μM) of HSGN-218 and control antibiotics against vancomycin-resistant enterococci (VRE) and Escherichia coli isolates.
    Caption A7 Compound Control Antibiotic E Faecium Atcc 700221 E, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caption+a7+antibiotic/Enterococcus+faecium+(Orla-Jensen)+Schleifer+and+Kilpper-Balz/pmc09064041-110-31-37
    Average 96 stars, based on 1 article reviews
    caption a7 compound control antibiotic e faecium atcc 700221 e - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    90
    ATCC caption a7 compound control antibiotic c difficile nr 13432
    MICs in μg/mL (μM) of HSGN-218 and control antibiotics against vancomycin-resistant enterococci (VRE) and Escherichia coli isolates.
    Caption A7 Compound Control Antibiotic C Difficile Nr 13432, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caption+a7+antibiotic/Curvularia+lunata+(Wakker)+Boedijn/pmc09064041-188-22-54
    Average 90 stars, based on 1 article reviews
    caption a7 compound control antibiotic c difficile nr 13432 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    99
    ATCC caption a7 antibiotic assay mic
    MICs in μg/mL (μM) of HSGN-218 and control antibiotics against vancomycin-resistant enterococci (VRE) and Escherichia coli isolates.
    Caption A7 Antibiotic Assay Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caption+a7+antibiotic/MIC/pmc08097427-78-24-33
    Average 99 stars, based on 1 article reviews
    caption a7 antibiotic assay mic - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    ATCC caption a7 antibiotic susceptibility
    <t>Antibiotic</t> <t>susceptibility</t> of UM001B, ATCC 29212, and B. subtilis 168. Van (A), Tet (B), and Amp (C) were tested at different concentrations. Exponential-phase planktonic cells cultured in LB medium were harvested and treated with each antibiotic for 3.5 h at 37°C, with shaking at 200 rpm. Each condition was tested with at least three biological replicates (n ≥ 3).
    Caption A7 Antibiotic Susceptibility, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caption+a7+antibiotic/A7/pmc07755234-86-25-31
    Average 96 stars, based on 1 article reviews
    caption a7 antibiotic susceptibility - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    ATCC caption a7 antibiotic mic
    <t>Antibiotic</t> <t>susceptibility</t> of UM001B, ATCC 29212, and B. subtilis 168. Van (A), Tet (B), and Amp (C) were tested at different concentrations. Exponential-phase planktonic cells cultured in LB medium were harvested and treated with each antibiotic for 3.5 h at 37°C, with shaking at 200 rpm. Each condition was tested with at least three biological replicates (n ≥ 3).
    Caption A7 Antibiotic Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caption+a7+antibiotic/MIC/pmc07449184-87-19-42
    Average 99 stars, based on 1 article reviews
    caption a7 antibiotic mic - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC caption a7 antibiotic s mic
    <t>Antibiotic</t> <t>susceptibility</t> of UM001B, ATCC 29212, and B. subtilis 168. Van (A), Tet (B), and Amp (C) were tested at different concentrations. Exponential-phase planktonic cells cultured in LB medium were harvested and treated with each antibiotic for 3.5 h at 37°C, with shaking at 200 rpm. Each condition was tested with at least three biological replicates (n ≥ 3).
    Caption A7 Antibiotic S Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caption+a7+antibiotic/MIC/pmc07375773-202-25-34
    Average 99 stars, based on 1 article reviews
    caption a7 antibiotic s mic - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    Journal: Journal of medicinal chemistry

    Article Title: Ultrapotent Inhibitor of Clostridioides difficile Growth, which Suppresses Recurrence in vivo

    doi: 10.1021/acs.jmedchem.0c01198

    Figure Lengend Snippet: MICs in μg/mL (μM) of HSGN-218 and control antibiotics against vancomycin-resistant enterococci (VRE) and Escherichia coli isolates.

    Article Snippet: Thus, the lack of activity against the wild-type E. coli could be attributed to that HSGN-218 may be a substrate for AcrAB-TolC efflux pump. table ft1 table-wrap mode="anchored" t5 Table 3. caption a7 Compound/Control Antibiotic E. faecium ATCC 700221 E. faecalis ATCC 51299 E. coli JW55031 (TolC Mutant E. coli BW25113 (wild-type strain) HSGN-218 0.125 (0.29) 0.06 (0.14) 4 (9.2) >16 (>36.8) Vancomycin 32 (22.1) >64 (>44.2) >64 (>44.2) >64 (>44.2) Metronidazole >64 (>373.9) >64 (>373.9) NT 1 NT Linezolid 1 (3.0) 1 (3.0) 16 (47.4) >64 (>189,7) Gentamicin NT NT 0.25 (0.52) 0.25 (0.52) Open in a separate window NT 1 , not tested MICs in μg/mL (μM) of HSGN-218 and control antibiotics against vancomycin-resistant enterococci (VRE) and Escherichia coli isolates.

    Techniques: Control, Mutagenesis

    Antibiotic susceptibility of UM001B, ATCC 29212, and B. subtilis 168. Van (A), Tet (B), and Amp (C) were tested at different concentrations. Exponential-phase planktonic cells cultured in LB medium were harvested and treated with each antibiotic for 3.5 h at 37°C, with shaking at 200 rpm. Each condition was tested with at least three biological replicates (n ≥ 3).

    Journal: Applied and Environmental Microbiology

    Article Title: High-Level Antibiotic Tolerance of a Clinically Isolated Enterococcus faecalis Strain

    doi: 10.1128/AEM.02083-20

    Figure Lengend Snippet: Antibiotic susceptibility of UM001B, ATCC 29212, and B. subtilis 168. Van (A), Tet (B), and Amp (C) were tested at different concentrations. Exponential-phase planktonic cells cultured in LB medium were harvested and treated with each antibiotic for 3.5 h at 37°C, with shaking at 200 rpm. Each condition was tested with at least three biological replicates (n ≥ 3).

    Article Snippet: Such high-level multidrug tolerance is remarkable and deserves further study. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window FIG 1 caption a7 Antibiotic susceptibility of UM001B, ATCC 29212, and B. subtilis 168.

    Techniques: Cell Culture